市場調査レポート

商品コード

1421749

眼科用医薬品市場、シェア、規模、動向、産業分析レポート：薬剤クラス別、疾患別、投与経路別、製品タイプ別、剤形別、地域別、セグメント別予測、2023年～2032年

Ophthalmic Drug Market Share, Size, Trends, Industry Analysis Report, By Drug Class ; By Disease; By Route of Administration; By Product Type; By Dosage Form; By Region; Segment Forecast, 2023 - 2032

出版日: 2023年12月23日 | 発行: Polaris Market Research

| ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,250 667,845円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 824,985円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 982,125円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Researchの最新調査によると、世界の眼科用医薬品市場規模は2032年までに735億7,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

眼科治療薬は、白内障、緑内障、糖尿病網膜症、近視性脈絡膜など、さまざまな眼疾患の治療において重要な役割を果たしています。特に、世界保健機関（WHO）によると、緑内障は世界第2位の失明原因となっています。同市場では、セファゾリン、ゲンタマイシン、EDTA、ベバシズマブなど、さまざまな眼科治療薬を提供しています。さらに、医療インフラの強化、世界の健康意識の向上を目指した政府の取り組み、先進的な薬剤の開発に向けた投資の増加といった要因も、市場成長の期待を後押ししています。

世界の高齢者人口の増加、先進国・新興国双方の緑内障患者数の増加、眼関連疾患に対する医療支出の増加などの要因により、予測期間中に市場収益シェアは拡大すると予想されます。

眼科用医薬品市場はCOVID-19の大流行により悪影響を受けた。例えば、2021年11月にClinical Ophthalmology Journalで報告されたように、パンデミック前とパンデミック後のデータを分析したところ、眼科医療の様々な側面で大幅な減少が見られました。パンデミック前とパンデミック後を比較すると、視野検査は93.84％、診察は92.52％、投薬は19.63％、手術は72.74％減少しました。このデータは、パンデミック時に緑内障やその他の眼科疾患の治療が大幅に減少したことを示しています。しかし、COVID-19ワクチンが広く利用できるようになり、COVID-19の症例数が減少し続けるにつれて、市場は回復すると予想されます。

さらに、2021年6月にNational Library of Medicineに掲載された研究では、冠動脈疾患（CAD）が世界の健康に与える影響の大きさが強調されました。CADだけで年間約61万人が死亡しており、死亡者の4人に1人を占めると推定され、米国における死亡原因の第一位となっています。CADの罹患率が上昇するにつれ、この差し迫った医療ニーズに対処するための効果的な眼科用薬剤装置の需要が高まっています。その結果、この要因は予測期間を通じて眼科用薬剤の需要を促進すると予測されています。

眼科用医薬品市場レポートハイライト

2022年には、抗炎症分野が市場を席巻し、最大の売上シェアを獲得しました。これは、眼アレルギーや炎症の治療を求める患者が増加していることに起因しています。同時に、抗VEGF分野は予測期間中に大きなCAGRを示すと予想されます。この成長は、糖尿病性網膜症や加齢黄斑変性などの疾患を含む網膜疾患の有病率の上昇に後押しされています。さらに、人口におけるこれらの疾患の診断率の上昇が、様々な地域における抗VEGF療法の需要を促進しています。

予測期間を通じて市場シェアを独占したのは半固形セグメントでした。このセグメントは、主に承認と製品上市の増加により、より高い年間平均成長率（CAGR）を達成すると予測されます。これらの承認には、軟膏、懸濁液、ゲルなど、さまざまな製品が含まれます。特に炎症性疾患、感染症、ドライアイの治療において軟膏の利用が増加していることが、その有効性の向上による人気の上昇に寄与しています。さらに、このセグメントの成長は、認可を確保し、より広範な製品を導入するための主要業界参入企業の努力の強化によってさらに推進されています。

2022年には、北米が最大市場としてトップの座を占めました。この優位性は、同地域における眼疾患の有病率の高さと、これらの疾患に対する人々の意識の高まりに影響されています。さらに、業界の主要参入企業による継続的な研究開発の努力は、この地域のさらなる成長に貢献すると予想されています。その他の特典として、北米にはファイザー社、アルコン社、ボシュロム社などの大手企業が存在し、市場での地位をさらに高めています。

点眼薬-業界スナップショット
眼科用医薬品市場力学
- 促進要因と機会
  - 臨床試験やパイプライン候補の増加により、革新的な医薬品や治療法の需要が高まっている
  - コンタクトレンズの利用が拡大
- 抑制要因と課題
  - 市場収益の成長は、特許のない医薬品や承認の遅れに直面している医薬品の入手可能性によって妨げられる可能性が高い
PESTLE分析
眼科用医薬品業界の動向
COVID-19感染症の影響分析

第5章世界の眼科用医薬品市場、薬剤クラス別

主要調査結果
イントロダクション
抗VEGF剤
抗緑内障
抗炎症
抗アレルギー
その他

第6章世界の眼科用医薬品市場、疾患別

主要調査結果
イントロダクション
緑内障
ドライアイ
網膜疾患
目アレルギー
眼感染症
その他

第7章世界の眼科用医薬品市場、投与経路別

主要調査結果
イントロダクション
全身性
局所
局所眼科
結膜下
硝子体内
網膜疾患
眼球後
前房内

第8章世界の眼科用医薬品市場、製品タイプ別

主要調査結果
イントロダクション
一般用医薬品
処方薬

第9章世界の眼科用医薬品市場、剤形別

主要調査結果
イントロダクション
半固体
液体
固体

第10章地域の世界の眼科用医薬品市場

主要調査結果
イントロダクション
- 眼科用医薬品市場評価、地域別、2019～2032年
眼科用医薬品市場-北米
- 北米：眼科用医薬品市場、薬剤クラス別、2019～2032年
- 北米：眼科用医薬品市場、製品タイプ別、2019～2032年
- 北米：眼科用医薬品市場、疾患別、2019～2032年
- 北米：眼科用医薬品市場、投与経路別、2019～2032年
- 北米：眼科用医薬品市場、剤形別、2019～2032年
- 眼科用医薬品市場-米国
- 眼科用医薬品市場-カナダ
眼科用医薬品市場-欧州
- 欧州：眼科用医薬品市場、薬剤クラス別、2019～2032年
- 欧州：眼科用医薬品市場、製品タイプ別、2019～2032年
- 欧州：眼科用医薬品市場、疾患別、2019～2032年
- 欧州：眼科用医薬品市場、投与経路別、2019～2032年
- 欧州：眼科用医薬品市場、剤形別、2019～2032年
- 眼科用医薬品市場-英国
- 眼科用医薬品市場-フランス
- 眼科用医薬品市場-ドイツ
- 眼科用医薬品市場-イタリア
- 眼科用医薬品市場-スペイン
- 眼科用医薬品市場-オランダ
- 眼科用医薬品市場-ロシア
眼科用医薬品市場-アジア太平洋
- アジア太平洋：眼科用医薬品市場、薬剤クラス別、2019～2032年
- アジア太平洋：眼科用医薬品市場、製品タイプ別、2019～2032年
- アジア太平洋：眼科用医薬品市場、疾患別、2019～2032年
- アジア太平洋：眼科用医薬品市場、投与経路別、2019～2032年
- アジア太平洋：眼科用医薬品市場、剤形別、2019～2032年
- 眼科用医薬品市場-中国
- 眼科用医薬品市場-インド
- 眼科用医薬品市場-日本
- 眼科用医薬品市場-マレーシア
- 眼科用医薬品市場-インドネシア
- 眼科用医薬品市場-韓国
眼科用医薬品市場-中東・アフリカ
- 中東・アフリカ：眼科用医薬品市場、薬剤クラス別、2019～2032年
- 中東・アフリカ：眼科用医薬品市場、製品タイプ別、2019～2032年
- 中東・アフリカ：眼科用医薬品市場、疾患別、2019～2032年
- 中東・アフリカ：眼科用医薬品市場、投与経路別、2019～2032年
- 中東・アフリカ：眼科用医薬品市場、剤形別、2019～2032年
- 眼科用医薬品市場-サウジアラビア
- 眼科用医薬品市場-アラブ首長国連邦
- 眼科用医薬品市場-イスラエル
- 眼科用医薬品市場-南アフリカ
眼科用医薬品市場-ラテンアメリカ
- ラテンアメリカ：眼科用医薬品市場、薬剤クラス別、2019～2032年
- ラテンアメリカ：眼科用医薬品市場、製品タイプ別、2019～2032年
- ラテンアメリカ：眼科用医薬品市場、疾患別、2019～2032年
- ラテンアメリカ：眼科用医薬品市場、投与経路別、2019～2032年
- ラテンアメリカ：眼科用医薬品市場、剤形別、2019～2032年
- 眼科用医薬品市場-メキシコ
- 眼科用医薬品市場-ブラジル
- 眼科用医薬品市場-アルゼンチン

第11章競合情勢

拡大と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第12章企業プロファイル

Alcon
Allergan（AbbVie Inc）
Bausch Health Companies Inc.
Bayer AG
Coherus Biosciences, Inc.
Genentech, Inc.（F. Hoffmann-La Roche Ltd）
Merck & Co., Inc
Nicox
Novartis AG
Pfizer Inc.
Regeneron Pharmaceuticals Inc

図表

List of Tables

Table 1 Global Ophthalmic Drug Market, by Drug Class, by Region, 2019-2032 (USD Billion)
Table 2 Global Ophthalmic Drug Market, by Disease, by Region, 2019-2032 (USD Billion)
Table 3 Global Ophthalmic Drug Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
Table 4 Global Ophthalmic Drug Market, by Dosage Form, by Region, 2019-2032 (USD Billion)
Table 5 Global Ophthalmic Drug Market, by Product Type, by Region, 2019-2032 (USD Billion)
Table 6 North America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 7 North America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 8 North America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 9 North America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 10 North America: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 11 U.S.: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 12 U.S.: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 13 U.S.: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 14 U.S.: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 15 U.S.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 16 Canada: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 17 Canada: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 18 Canada: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 19 Canada: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 20 Canada: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 21 Europe: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 22 Europe: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 23 Europe: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 24 Europe: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 25 Europe: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 26 Germany: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 27 Germany: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 28 Germany: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 29 Germany: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 30 Germany: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 31 France: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 32 France: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 33 France: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 34 France: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 35 France: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 36 UK: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 37 UK: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 38 UK: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 39 UK: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 40 UK: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 41 Italy: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 42 Italy: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 43 Italy: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 44 Italy: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 45 Italy: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 46 Netherlands: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 47 Netherlands: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 48 Netherlands: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 49 Netherlands: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 50 Netherlands: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 51 Spain: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 52 Spain: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 53 Spain: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 54 Spain: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 55 Spain: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 56 Russia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 57 Russia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 58 Russia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 59 Russia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 60 Russia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 61 Asia Pacific: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 62 Asia Pacific: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 63 Asia Pacific: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 64 Asia Pacific: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 65 Asia Pacific: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 66 China: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 67 China: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 68 China: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 69 China: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 70 China: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 71 Japan: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 72 Japan: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 73 Japan: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 74 Japan: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 75 Japan: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 76 India: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 77 India: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 78 India: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 79 India: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 80 India: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 81 Indonesia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 82 Indonesia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 83 Indonesia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 84 Indonesia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 85 Indonesia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 86 Malaysia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 87 Malaysia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 88 Malaysia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 89 Malaysia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 90 Malaysia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 91 South Korea: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 92 South Korea: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 93 South Korea: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 94 South Korea: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 95 South Korea: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 96 Latin America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 97 Latin America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 98 Latin America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 99 Latin America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 100 Latin America: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 101 Brazil: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 102 Brazil: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 103 Brazil: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 104 Brazil: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 105 Brazil: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 106 Mexico: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 107 Mexico: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 108 Mexico: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 109 Mexico: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 110 Mexico: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 111 Argentina: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 112 Argentina: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 113 Argentina: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 114 Argentina: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 115 Argentina: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 116 Middle East & Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 117 Middle East & Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 118 Middle East & Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 119 Middle East & Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 120 Middle East & Africa: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 121 UAE: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 122 UAE: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 123 UAE: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 124 UAE: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 125 UAE: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 126 Saudi Arabia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 127 Saudi Arabia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 128 Saudi Arabia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 129 Saudi Arabia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 130 Saudi Arabia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 131 South Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 132 South Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 133 South Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 134 South Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 135 South Africa: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
Table 136 Israel: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
Table 137 Israel: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
Table 138 Israel: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
Table 139 Israel: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
Table 140 Israel: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)

List of Figures

Figure 1. Global Ophthalmic Drug Market, 2019-2032 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Drug Class
Figure 7. Global Ophthalmic Drug Market, by Drug Class, 2021 & 2030 (USD Billion)
Figure 8. Market by Disease
Figure 9. Global Ophthalmic Drug Market, by Disease, 2021 & 2030 (USD Billion)
Figure 10. Market by Route of Administration
Figure 11. Global Ophthalmic Drug Market, by Route of Administration, 2021 & 2030 (USD Billion)
Figure 12. Market by Dosage Form
Figure 13. Global Ophthalmic Drug Market, by Dosage Form, 2021 & 2030 (USD Billion)
Figure 14. Market by Product Type
Figure 15. Global Ophthalmic Drug Market, by Product Type, 2021 & 2030 (USD Billion)

Product Code: PM4073

The global ophthalmic drug market size is expected to reach USD 73.57 billion by 2032, according to a new study by Polaris Market Research. The report "Opthalmic Drug Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Anti-VEGF Agents, Anti-glaucoma, Anti-inflammatory, Antiallergy, Others); By Disease; By Route of Administration; By Product Type; By Dosage Form; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Ophthalmic drugs play a crucial role in the treatment of a range of eye diseases, including cataracts, glaucoma, diabetic retinopathy, myopic choroidal, and others. Notably, glaucoma, according to the World Health Organization (WHO), stands as the second leading cause of blindness worldwide. The market offers a variety of ophthalmology medications, such as cefazolin, gentamicin, EDTA, bevacizumab, and more. Furthermore, the anticipation of market growth is bolstered by factors such as enhanced healthcare infrastructure, government initiatives aimed at raising global health awareness, and increased investments in the development of advanced drug types.

The market revenue share is expected to grow during the forecast period due to factors like the increasing global elderly population, a rising number of glaucoma patients in both developed and developing countries, and higher healthcare spending on eye-related diseases.

The ophthalmic drugs market experienced adverse effects due to the COVID-19 pandemic. For instance, as reported in the Clinical Ophthalmology Journal in November 2021, an analysis of data from pre-pandemic and post-pandemic periods revealed a substantial decline in various aspects of eye care. Visual field checkups, clinical visits, medication releases, and surgical procedures saw reductions of 93.84%, 92.52%, 19.63%, and 72.74% when comparing the pre-pandemic and post-pandemic times. This data indicates a significant decrease in the treatment of glaucoma and other ophthalmic disorders during the pandemic. However, the market is expected to rebound as COVID-19 vaccines become widely available and the number of COVID-19 cases continues to decline.

Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective Opthalmic Drug devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for Opthalmic Drugs throughout the forecast period.

Opthalmic Drug Market Report Highlights

In 2022, the Anti-inflammatory segment dominated the market, capturing the largest share of revenue. This can be attributed to the increasing number of patients seeking treatment for ocular allergies and inflammation. Concurrently, the Anti-VEGF segment is expected to show a significant CAGR over the forecast period. This growth is propelled by the escalating prevalence of retinal disorders, including conditions like diabetic retinopathy and age-related macular degeneration, among others. Furthermore, the rising rate of diagnosis for these conditions within the population is fueling the demand for anti-VEGF therapy across various regions.

The Semisolid segment dominated the market share throughout the forecast period. This segment is anticipated to achieve a higher Compound Annual Growth Rate (CAGR), mainly due to the increasing number of approvals and product launches. These approvals encompass a range of products, including ointments, suspensions, gels, and others. The growing utilization of ointments, particularly in the treatment of inflammatory conditions, infections, and dry eye, has contributed to their rising popularity due to their enhanced effectiveness. Furthermore, the segment's growth is further propelled by the intensified efforts of key industry players to secure approvals and introduce a wider array of products.

In 2022, North America held the top position as the largest market. This dominance is influenced by a higher prevalence of eye diseases in the region and an increasing awareness of these conditions among the population. Moreover, the continuous research and development endeavors by key industry players are anticipated to contribute to the further growth of the region. Additionally, North America benefits from the presence of major players such as Pfizer Inc., Alcon, and Bausch and Lomb, which further bolster its market position.

The global key market players include: es, Inc., Genentech, Inc. (F. Hoffmann-La Roche Ltd), Merck & Co., Inc., Nicox, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc.

Polaris Market Research has segmented the Opthalmic Drug market report based on disease, drug class, route of administration, dosage form, product type, and region:

Opthalmic Drug, Disease Outlook (Revenue - USD Billion, 2019 - 2032)

Glaucoma
Dry Eye
Retinal Disorders
Eye Allergy
Eye Infection
Others

Opthalmic Drug, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

Anti-VEGF Agents
Anti-glaucoma
Anti-inflammatory
Steroidal drugs
Non-steroidal drugs
Antiallergy
Others

Opthalmic Drug, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Systemic
Topical
Local Ocular
Subconjunctival
Intravitreal
Retinal Disorders
Retrobulbar
Intracameral

Opthalmic Drug, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)

OTC Drugs
Prescription Drugs

Opthalmic Drug, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

Semisolid
Liquid
Solid

Opthalmic Drug, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Ophthalmic Drug Market Insights

4.1. Ophthalmic Drug - Industry Snapshot
4.2. Ophthalmic Drug Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Propelled by increasing clinical trials and pipeline candidates, demand for innovative drugs and therapies is on the rise
  - 4.2.1.2. Growing utilization of contact lenses
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. The growth in market revenue is likely to be hampered by the availability of drugs without patents and those facing delayed approval
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Ophthalmic Drug Industry Trends
4.6. COVID-19 Impact Analysis

5. Global Ophthalmic Drug Market, by Drug Class

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
5.3. Anti-VEGF Agents
- 5.3.1. Global Ophthalmic Drug Market, by Anti-VEGF Agents, by Region, 2019-2032 (USD Billion)
5.4. Anti-glaucoma
- 5.4.1. Global Ophthalmic Drug Market, by Anti-glaucoma, by Region, 2019-2032 (USD Billion)
5.5. Anti-inflammatory
- 5.5.1. Global Ophthalmic Drug Market, by Anti-inflammatory, by Region, 2019-2032 (USD Billion)
- 5.5.2. Steroidal drugs
  - 5.5.2.1. Global Ophthalmic Drug Market, by Steroidal drugs, by Region, 2019-2032 (USD Billion)
- 5.5.3. Non-steroidal drugs
  - 5.5.3.1. Global Ophthalmic Drug Market, by Non-steroidal drugs, by Region, 2019-2032 (USD Billion)
5.6. Antiallergy
- 5.6.1. Global Ophthalmic Drug Market, by Antiallergy, by Region, 2019-2032 (USD Billion)
5.7. Others
- 5.7.1. Global Ophthalmic Drug Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Ophthalmic Drug Market, by Disease

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
6.3. Glaucoma
- 6.3.1. Global Ophthalmic Drug Market, by Glaucoma, by Region, 2019-2032 (USD Billion)
6.4. Dry Eye
- 6.4.1. Global Ophthalmic Drug Market, by Dry Eye, by Region, 2019-2032 (USD Billion)
6.5. Retinal Disorders
- 6.5.1. Global Ophthalmic Drug Market, by Retinal Disorders, by Region, 2019-2032 (USD Billion)
6.6. Eye Allergy
- 6.6.1. Global Ophthalmic Drug Market, by Eye Allergy, by Region, 2019-2032 (USD Billion)
6.7. Eye Infection
- 6.7.1. Global Ophthalmic Drug Market, by Eye Infection, by Region, 2019-2032 (USD Billion)
6.8. Others
- 6.8.1. Global Ophthalmic Drug Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Ophthalmic Drug Market, by Route of Administration

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
7.3. Systemic
- 7.3.1. Global Ophthalmic Drug Market, by Systemic, by Region, 2019-2032 (USD Billion)
7.4. Topical
- 7.4.1. Global Ophthalmic Drug Market, by Topical, by Region, 2019-2032 (USD Billion)
7.5. Local Ocular
- 7.5.1. Global Ophthalmic Drug Market, by Local Ocular, by Region, 2019-2032 (USD Billion)
7.6. Subconjunctival
- 7.6.1. Global Ophthalmic Drug Market, by Subconjunctival, by Region, 2019-2032 (USD Billion)
7.7. Intravitreal
- 7.7.1. Global Ophthalmic Drug Market, by Intravitreal, by Region, 2019-2032 (USD Billion)
7.8. Retinal Disorders
- 7.8.1. Global Ophthalmic Drug Market, by Retinal Disorders, by Region, 2019-2032 (USD Billion)
7.9. Retrobulbar
- 7.9.1. Global Ophthalmic Drug Market, by Retrobulbar, by Region, 2019-2032 (USD Billion)
7.10. Intracameral
- 7.10.1. Global Ophthalmic Drug Market, by Intracameral, by Region, 2019-2032 (USD Billion)

8. Global Ophthalmic Drug Market, by Product Type

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
8.3. OTC Drugs
- 8.3.1. Global Ophthalmic Drug Market, by OTC Drugs, by Region, 2019-2032 (USD Billion)
8.4. Prescription Drugs
- 8.4.1. Global Ophthalmic Drug Market, by Prescription Drugs, by Region, 2019-2032 (USD Billion)

9. Global Ophthalmic Drug Market, by Dosage Form

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
9.3. Semisolid
- 9.3.1. Global Ophthalmic Drug Market, by Semisolid, by Region, 2019-2032 (USD Billion)
9.4. Liquid
- 9.4.1. Global Ophthalmic Drug Market, by Liquid, by Region, 2019-2032 (USD Billion)
9.5. Solid
- 9.5.1. Global Ophthalmic Drug Market, by Solid, by Region, 2019-2032 (USD Billion)

10. Global Ophthalmic Drug Market, by Geography

10.1. Key findings
10.2. Introduction
- 10.2.1. Ophthalmic Drug Market Assessment, By Geography, 2019-2032 (USD Billion)
10.3. Ophthalmic Drug Market - North America
- 10.3.1. North America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
- 10.3.2. North America: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
- 10.3.3. North America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
- 10.3.4. North America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
- 10.3.5. North America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.3.6. Ophthalmic Drug Market - U.S.
  - 10.3.6.1. U.S.: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.3.6.2. U.S.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.3.6.3. U.S.: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.3.6.4. U.S.: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.3.6.5. U.S.: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.3.7. Ophthalmic Drug Market - Canada
  - 10.3.7.1. Canada: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.3.7.2. Canada.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.3.7.3. Canada: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.3.7.4. Canada: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.3.7.5. Canada: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
10.4. Ophthalmic Drug Market - Europe
- 10.4.1. Europe: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
- 10.4.2. Europe.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
- 10.4.3. Europe: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
- 10.4.4. Europe: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
- 10.4.5. Europe: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.4.6. Ophthalmic Drug Market - UK
  - 10.4.6.1. UK: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.4.6.2. UK.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.4.6.3. UK: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.4.6.4. UK: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.6.5. UK: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.4.7. Ophthalmic Drug Market - France
  - 10.4.7.1. France: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.4.7.2. France.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.4.7.3. France: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.4.7.4. France: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.7.5. France: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.4.8. Ophthalmic Drug Market - Germany
  - 10.4.8.1. Germany: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.4.8.2. Germany.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.4.8.3. Germany: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.4.8.4. Germany: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.8.5. Germany: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.4.9. Ophthalmic Drug Market - Italy
  - 10.4.9.1. Italy: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.4.9.2. Italy.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.4.9.3. Italy: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.4.9.4. Italy: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.9.5. Italy: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.4.10. Ophthalmic Drug Market - Spain
  - 10.4.10.1. Spain: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.4.10.2. Spain.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.4.10.3. Spain: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.4.10.4. Spain: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.10.5. Spain: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.4.11. Ophthalmic Drug Market - Netherlands
  - 10.4.11.1. Netherlands: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.4.11.2. Netherlands.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.4.11.3. Netherlands: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.4.11.4. Netherlands: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.11.5. Netherlands: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.4.12. Ophthalmic Drug Market - Russia
  - 10.4.12.1. Russia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.4.12.2. Russia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.4.12.3. Russia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.4.12.4. Russia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.4.12.5. Russia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
10.5. Ophthalmic Drug Market - Asia Pacific
- 10.5.1. Asia Pacific: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
- 10.5.2. Asia Pacific.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
- 10.5.3. Asia Pacific: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
- 10.5.4. Asia Pacific: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
- 10.5.5. Asia Pacific: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.5.6. Ophthalmic Drug Market - China
  - 10.5.6.1. China: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.5.6.2. China.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.5.6.3. China: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.5.6.4. China: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.6.5. China: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.5.7. Ophthalmic Drug Market - India
  - 10.5.7.1. India: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.5.7.2. India.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.5.7.3. India: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.5.7.4. India: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.7.5. India: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.5.8. Ophthalmic Drug Market - Japan
  - 10.5.8.1. Japan: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.5.8.2. Japan.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.5.8.3. Japan: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.5.8.4. Japan: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.8.5. Japan: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.5.9. Ophthalmic Drug Market - Malaysia
  - 10.5.9.1. Malaysia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.5.9.2. Malaysia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.5.9.3. Malaysia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.5.9.4. Malaysia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.9.5. Malaysia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.5.10. Ophthalmic Drug Market - Indonesia
  - 10.5.10.1. Indonesia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.5.10.2. Indonesia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.5.10.3. Indonesia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.5.10.4. Indonesia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.10.5. Indonesia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.5.11. Ophthalmic Drug Market - South Korea
  - 10.5.11.1. South Korea: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.5.11.2. South Korea.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.5.11.3. South Korea: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.5.11.4. South Korea: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.5.11.5. South Korea: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
10.6. Ophthalmic Drug Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
- 10.6.2. Middle East & Africa: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
- 10.6.3. Middle East & Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
- 10.6.4. Middle East & Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
- 10.6.5. Middle East & Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.6.6. Ophthalmic Drug Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.6.6.2. Saudi Arabia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.6.6.3. Saudi Arabia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.6.6.4. Saudi Arabia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.6.6.5. Saudi Arabia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.6.7. Ophthalmic Drug Market - UAE
  - 10.6.7.1. UAE: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.6.7.2. UAE.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.6.7.3. UAE: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.6.7.4. UAE: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.6.7.5. UAE: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.6.8. Ophthalmic Drug Market - Israel
  - 10.6.8.1. Israel: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.6.8.2. Israel.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.6.8.3. Israel: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.6.8.4. Israel: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.6.8.5. Israel: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.6.9. Ophthalmic Drug Market - South Africa
  - 10.6.9.1. South Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.6.9.2. South Africa.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.6.9.3. South Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.6.9.4. South Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.6.9.5. South Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
10.7. Ophthalmic Drug Market - Latin America
- 10.7.1. Latin America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
- 10.7.2. Latin America.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
- 10.7.3. Latin America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
- 10.7.4. Latin America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
- 10.7.5. Latin America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.7.6. Ophthalmic Drug Market - Mexico
  - 10.7.6.1. Mexico: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.7.6.2. Mexico.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.7.6.3. Mexico: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.7.6.4. Mexico: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.7.6.5. Mexico: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.7.7. Ophthalmic Drug Market - Brazil
  - 10.7.7.1. Brazil: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.7.7.2. Brazil.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.7.7.3. Brazil: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.7.7.4. Brazil: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.7.7.5. Brazil: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
- 10.7.8. Ophthalmic Drug Market - Argentina
  - 10.7.8.1. Argentina: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  - 10.7.8.2. Argentina.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  - 10.7.8.3. Argentina: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  - 10.7.8.4. Argentina: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  - 10.7.8.5. Argentina: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Alcon
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Allergan (AbbVie Inc)
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Bausch Health Companies Inc.
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. Bayer AG
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. Coherus Biosciences, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Genentech, Inc. (F. Hoffmann-La Roche Ltd)
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. Merck & Co., Inc
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Nicox
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Novartis AG
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Pfizer Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. Regeneron Pharmaceuticals Inc
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development

眼科用医薬品市場、シェア、規模、動向、産業分析レポート：薬剤クラス別、疾患別、投与経路別、製品タイプ別、剤形別、地域別、セグメント別予測、2023年～2032年

Ophthalmic Drug Market Share, Size, Trends, Industry Analysis Report, By Drug Class ; By Disease; By Route of Administration; By Product Type; By Dosage Form; By Region; Segment Forecast, 2023 - 2032

眼科用医薬品市場レポートハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の眼科用医薬品市場の洞察

第5章世界の眼科用医薬品市場、薬剤クラス別

第6章世界の眼科用医薬品市場、疾患別

第7章世界の眼科用医薬品市場、投与経路別

第8章世界の眼科用医薬品市場、製品タイプ別

第9章世界の眼科用医薬品市場、剤形別

第10章地域の世界の眼科用医薬品市場

第11章競合情勢

第12章企業プロファイル

List of Tables

List of Figures

Opthalmic Drug Market Report Highlights

Opthalmic Drug, Disease Outlook (Revenue - USD Billion, 2019 - 2032)

Opthalmic Drug, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

Opthalmic Drug, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Opthalmic Drug, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)

Opthalmic Drug, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

Opthalmic Drug, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Ophthalmic Drug Market Insights

5. Global Ophthalmic Drug Market, by Drug Class

6. Global Ophthalmic Drug Market, by Disease

7. Global Ophthalmic Drug Market, by Route of Administration

8. Global Ophthalmic Drug Market, by Product Type

9. Global Ophthalmic Drug Market, by Dosage Form

10. Global Ophthalmic Drug Market, by Geography

11. Competitive Landscape

12. Company Profiles

眼科用医薬品市場、シェア、規模、動向、産業分析レポート：薬剤クラス別、疾患別、投与経路別、製品タイプ別、剤形別、地域別、セグメント別予測、2023年～2032年

Ophthalmic Drug Market Share, Size, Trends, Industry Analysis Report, By Drug Class ; By Disease; By Route of Administration; By Product Type; By Dosage Form; By Region; Segment Forecast, 2023 - 2032

眼科用医薬品市場レポートハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の眼科用医薬品市場の洞察

第5章 世界の眼科用医薬品市場、薬剤クラス別

第6章 世界の眼科用医薬品市場、疾患別

第7章 世界の眼科用医薬品市場、投与経路別

第8章 世界の眼科用医薬品市場、製品タイプ別

第9章 世界の眼科用医薬品市場、剤形別

第10章 地域の世界の眼科用医薬品市場

第11章 競合情勢

第12章 企業プロファイル

List of Tables

List of Figures

Opthalmic Drug Market Report Highlights

Opthalmic Drug, Disease Outlook (Revenue - USD Billion, 2019 - 2032)

Opthalmic Drug, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

Opthalmic Drug, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Opthalmic Drug, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)

Opthalmic Drug, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

Opthalmic Drug, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Ophthalmic Drug Market Insights

5. Global Ophthalmic Drug Market, by Drug Class

6. Global Ophthalmic Drug Market, by Disease

7. Global Ophthalmic Drug Market, by Route of Administration

8. Global Ophthalmic Drug Market, by Product Type

9. Global Ophthalmic Drug Market, by Dosage Form

10. Global Ophthalmic Drug Market, by Geography

11. Competitive Landscape

12. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の眼科用医薬品市場の洞察

第5章世界の眼科用医薬品市場、薬剤クラス別

第6章世界の眼科用医薬品市場、疾患別

第7章世界の眼科用医薬品市場、投与経路別

第8章世界の眼科用医薬品市場、製品タイプ別

第9章世界の眼科用医薬品市場、剤形別

第10章地域の世界の眼科用医薬品市場

第11章競合情勢

第12章企業プロファイル